Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFIDEROCOL vs CEFPODOXIME PROXETIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFIDEROCOL vs CEFPODOXIME PROXETIL: Safety Overview

Metric CEFIDEROCOL CEFPODOXIME PROXETIL
Total FAERS Reports 649 323
Deaths Reported 359 5
Death Rate 55.3% 1.5%
Hospitalizations 134 160
Average Patient Age 57.0 yrs 52.9 yrs
% Female Patients 37.9% 70.0%
FDA Approval Date Nov 14, 2019 Aug 20, 2003
Manufacturer Shionogi Inc. Amici Pharmaceuticals, LLC.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued